Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
US11512141B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2018 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Jul 22, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are anti-FGL2 monoclonal antibodies. Further provided herein are methods to reverse suppressive immune mechanisms, such as for the treatment of cancer or infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.